Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Alderson

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|May 1, 1982
Discharge rates for nephritis and nephrosisM R Alderson, J S Ashley
International Immunology|January 1, 1989
Recombinant human interleukin 6 (B cell stimulatory factor 2) enhances immunoglobulin secretion by single murine hapten-specific B cells in the absence of cell divisionM R Alderson, B L Pike
British Journal of Industrial Medicine|August 1, 1983
Epidemiological survey of maintenance workers in London Transport Executive bus garages and Chiswick WorksL Rushton, M R Alderson, C R Nagarajah
Stem Cells (Dayton, Ohio)|September 1, 1994
The activation antigen CD69S F Ziegler, F Ramsdell, M R Alderson
British Journal of Cancer|December 1, 1971
The relative significance of prognostic factors in breast carcinomaM R Alderson, I Hamlin, M D Staunton
Journal of Epidemiology and Community Health|December 1, 1985
Risks of lung cancer, chronic bronchitis, ischaemic heart disease, and stroke in relation to type of cigarette smokedM R Alderson, P N Lee, R Wang
British Journal of Industrial Medicine|May 1, 1981
Health of workmen in the chromate-producing industry in BritainM R Alderson, N S Rattan, L Bidstrup
Journal of Clinical Pathology|May 1, 1970
Validity of the British system for anticoagulant control using the national reagentM R Alderson, L Poller, J M Thomson
Journal of Clinical Pathology|March 1, 1971
The British system for anticoagulant control and ThrombotestL Poller, J M Thomson, M R Alderson
British Medical Journal (Clinical Research Ed.)|August 25, 1984
Death certification in cancer of the breastD Brinkley, J L Haybittle, M R Alderson
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|May 1, 1982
Discharge rates for nephritis and nephrosisM R Alderson, J S Ashley
International Immunology|January 1, 1989
Recombinant human interleukin 6 (B cell stimulatory factor 2) enhances immunoglobulin secretion by single murine hapten-specific B cells in the absence of cell divisionM R Alderson, B L Pike
British Journal of Industrial Medicine|August 1, 1983
Epidemiological survey of maintenance workers in London Transport Executive bus garages and Chiswick WorksL Rushton, M R Alderson, C R Nagarajah
Stem Cells (Dayton, Ohio)|September 1, 1994
The activation antigen CD69S F Ziegler, F Ramsdell, M R Alderson
British Journal of Cancer|December 1, 1971
The relative significance of prognostic factors in breast carcinomaM R Alderson, I Hamlin, M D Staunton
Journal of Epidemiology and Community Health|December 1, 1985
Risks of lung cancer, chronic bronchitis, ischaemic heart disease, and stroke in relation to type of cigarette smokedM R Alderson, P N Lee, R Wang
British Journal of Industrial Medicine|May 1, 1981
Health of workmen in the chromate-producing industry in BritainM R Alderson, N S Rattan, L Bidstrup
Journal of Clinical Pathology|May 1, 1970
Validity of the British system for anticoagulant control using the national reagentM R Alderson, L Poller, J M Thomson
Journal of Clinical Pathology|March 1, 1971
The British system for anticoagulant control and ThrombotestL Poller, J M Thomson, M R Alderson
British Medical Journal (Clinical Research Ed.)|August 25, 1984
Death certification in cancer of the breastD Brinkley, J L Haybittle, M R Alderson
Pageof 10